Antiarrhythmic class III process

Details Antiarrhythmic class III process Antiarrhythmic class III process

1986-12-23

1992-02-18

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514821, A61K 3118

Patent

active

050895265

ABSTRACT:
A process is provided for preventing or ameliorating arrhythmia by administering to mammals, including man, an effective dose of d-sotalol to lengthen the action potential duration of cardiac cell without blockade of beta-adrenergic receptor sites.

REFERENCES:
patent: 3341584 (1967-09-01), Larsen et al.
N. Edvardsson, Current Therapeutic Research, 28, No. 1 Supplement, pp. 113S-118S, Jul. 1980.
Keefe et al, Drugs, 22, 363-400 (1981).
N. Edvardsson et al., European Heart Journal, 1, 335-343 (1980).
D. E. Ward et al., Clin. Cardiol., 2, 185-191 (1979).
D. P. Myburgh et al., SA Medical Journal, 295-298 (Aug. 1979).
L. D. Davis et al., Research in Physiology, 99-114, A. Gaggi Publisher, Bologna (1971).
B. N. Singh et al., Br. J. Pharmac., 39, 675-687 (1970).
D. C. Kvam et al., J. Pharm. Exper. Therap., 149(2), 183-193 (1965).
J. V. Levy et al., Proc. Soc. Exp. Biol. Med., 122, 373-379 (1966).
P. Somani et al., J. Pharm. Exper. Therap., 164(2), 317-326 (1968).
D. A. Lathrop, Can. J. Physiol. Pharmacol., vol. 63, 1506-1512 (1985).

Affiliated with

Also associated with

Rating

Antiarrhythmic class III process does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiarrhythmic class III process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarrhythmic class III process will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1823932